Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Let's get started...
Best Investments/trading ideas for the weekJoin our free webinar on September23,2026.

Let's get started...
| Role | Insider | Date | Transaction | Value | Shares |
|---|---|---|---|---|---|
| Chief Technology Officer | Tyagarajan Seshu | Aug 17, 2026 | Sell | $84K | 7,000 |
| Chief Technology Officer | Tyagarajan Seshu | Jun 29, 2026 | Sell | $70.15K | 7,000 |
| Chief Scientific Officer | Barone Francesca | Jun 29, 2026 | Sell | $235.77K | 23,447 |
| Director | Manning Paul B | Feb 23, 2026 | Buy | $3M | 550,458 |
| Chief Medical Officer | Nichols William Garrett | Jul 28, 2025 | Sell | $6.54K | 937 |
| Chief Medical Officer | Nichols William Garrett | Jun 30, 2025 | Sell | $3.94K | 781 |
| CEO | Tak Paul Peter | Mar 19, 2025 | Sell | $3.6K | 400 |
| CEO | Tak Paul Peter | Mar 18, 2025 | Sell | $226.02K | 25,772 |
| Chief Scientific Officer | Barone Francesca | Mar 18, 2025 | Sell | $281.67K | 32,146 |
| Chief Medical Officer | Nichols William Garrett | Mar 18, 2025 | Sell | $397K | 45,316 |
| See Remarks | Schoch Charles | Mar 17, 2025 | Sell | $44.17K | 5,000 |
| Chief Technology Officer | Tyagarajan Seshu | Mar 17, 2025 | Sell | $275.95K | 31,278 |
| Chief Medical Officer | Nichols William Garrett | Jan 15, 2025 | Sell | $75.34K | 10,428 |
| Chief Technology Officer | Tyagarajan Seshu | Jan 15, 2025 | Sell | $103.48K | 14,322 |
| CEO | Tak Paul Peter | Jan 15, 2025 | Sell | $156.81K | 21,704 |
| Chief Scientific Officer | Barone Francesca | Jan 15, 2025 | Sell | $97.78K | 13,534 |
| See Remarks | Schoch Charles | Jan 15, 2025 | Sell | $68.72K | 9,511 |
| CEO | Tak Paul Peter | Jan 8, 2025 | Sell | $174K | 21,172 |
| Chief Medical Officer | Nichols William Garrett | Jan 8, 2025 | Sell | $88.75K | 10,799 |
| See Remarks | Schoch Charles | Jan 8, 2025 | Sell | $81.94K | 9,971 |
| Chief Technology Officer | Tyagarajan Seshu | Jan 8, 2025 | Sell | $119.53K | 14,545 |
| Chief Scientific Officer | Barone Francesca | Jan 8, 2025 | Sell | $112.37K | 13,673 |
| Director | Manning Paul B | Dec 16, 2024 | Buy | $3M | 500,000 |
| Director | Manning Paul B | Dec 16, 2024 | Buy | $4.5M | 750,000 |
| Chief Scientific Officer | Barone Francesca | Nov 29, 2024 | Sell | $100.59K | 22,081 |
Open-market purchases and sales reported on SEC form 4 over the last 10years. Awards, option exercises, gifts and other non-market form 4 activity are excluded. Chart markers group a day's filings by direction; the table lists each filing.